logo
logo

Nanopath Inc. received $4m in federal funding to support the development of its point-of-care diagnostic platform for women’s health.

Nanopath Inc. received $4m in federal funding to support the development of its point-of-care diagnostic platform for women’s health.

05/21/24, 8:58 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$4 million
Industry
biotechnology
health care
Round Type
seed
Nanopath Inc., a point-of-care diagnostics company, received $4m in federal funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF) through the Small Business Innovation Research (SBIR) Program. The funding will support the development of its point-of-care diagnostic platform for women’s health.

Company Info

Company
Nanopath
Location
cambridge, massachusetts, united states
Additional Info
Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

Related People